期刊文献+

鲍曼不动杆菌所致感染的临床分析 被引量:3

Clinical analysis of infection caused by Acinetobacter baumannii
暂未订购
导出
摘要 目的了解鲍曼不动杆菌的临床分布情况及细菌对抗生素的耐药情况。方法分析126株鲍曼不动杆菌标本的来源、科室分布、抗生素耐药性。结果 95例鲍曼不动杆菌感染最常见的为呼吸系统疾病,标本以痰液为最多;耐药情况较重,耐药率最低的为多粘菌素B,其次为丁胺卡那及米诺环素,亚胺培南、美罗培南及头孢哌酮舒巴坦耐药率较高;患者全部有应用抗生素病史;多重耐药及泛耐药鲍曼不动杆菌共占菌株数的96.03%。结论加强对鲍曼不动杆菌耐药性的监控,减少耐药菌株的产生。 Objective To learn the distribution of Acinetobacter baumannii bacteria in clinical and the drug resistance to common antibiotics.Methods A retrospective statistical analysis of 126 specimens of Acinetobacter baumannii,including specimen source,distribution departments of sample sections,antibiotic resistance,and general conditiong of the patients was made.Results The most common primary diseases of 95 patients infected by Acinetobacter baumannii were respiratory system diseases.Acinetobacter baumannii was mostly detected by sputum samples.The resistance of Acinetobacter baumannii was serious.Polymyxin B had the lowest resistance,amikacin and minocycline next to it.Imipenem,meropenem and Cefperazone Sulbactam had higher resistance.All patients had history of using antibiotics.Multi-drug resistant and Pan-drug resistant Acinetobacter baumannii were accounted for 96.03%.Conclusions The clinicians should use antibiotics reasonably,strengthen the monitoring of Acinetobacter baumannii resistance and reduce drug resistant strains.
出处 《临床肺科杂志》 2012年第4期638-639,共2页 Journal of Clinical Pulmonary Medicine
关键词 鲍曼不动杆菌 耐药性 感染 Acinetobacter baumannii Drug resistance Infection
  • 相关文献

参考文献6

二级参考文献43

共引文献557

同被引文献19

  • 1邹明祥,范学工,梁湘辉,刘文恩,李宪.2003年湘雅医院临床分离菌的分布及耐药性分析[J].实用预防医学,2006,13(2):241-243. 被引量:12
  • 2吴建曾,钟馥霞.139例鲍曼不动杆菌的院内感染及耐药性分析[J].广东医学院学报,2006,24(3):260-261. 被引量:2
  • 3Perez F, Hujer AM, Hujer KM, et al. Global challenge of multi- drug- resistant Acinetobacter baumannii [ J ]. Antimicrob Agents Chemother, 2007, 51 (10) : 3471 - 3484.
  • 4National Nosocomial Infections Surveillance System. National Noso- comial Infections Surveillance (NNIS) System Report, data summa-ry from January 1992 through June 2004, issued October 2004[ J]. Am J Infect Control, 2004, 32(8) : 470 -485.
  • 5Karageorgopoulous DE, Falagas ME. Current control and treatment of muhidrug-resistant Acinetobacter baumannii infections [ J ]. Lan- cet Infect Dis, 2008, 8(12) : 751 -762.
  • 6Neonakis IK,Spandidos DA,Petinaki E.Confronting multidrug-resistant Acinetobacter baumannii:a review[J].Int J Antimicrob Agents,2011,37(2):102-109.
  • 7Bergogne-Bérézin E,Towner KJ.Acinetobacter spp.as nosocomial pathogens:microbiological,clinical,and epidemiological features[J].Clin Microbiol Rev,1996,9(2):148-165.
  • 8Nemec A,Dolzani L,Brisse S,et al.Diversity of aminoglycoside-resistance genes and their association with class 1integrons among strains of pan-European Acinetobacter baumannii clones[J].J Med Microbiol,2004,53(Pt12):1233-1240.
  • 9朱志斌,雷鸣.鲍曼不动杆菌的医院感染分布及耐药性研究[J].实用预防医学,2008,15(1):219-221. 被引量:32
  • 10朱健铭,姜如金,糜祖煌.多重耐药鲍曼不动杆菌存在新的氨基糖苷类药物耐药机制[J].世界感染杂志,2008,8(1):20-23. 被引量:17

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部